Triple
T22405319
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Regulation (EC) No 1902/2006 |
E553864
|
entity |
| Predicate | field |
P3
|
FINISHED |
| Object | EU medicines regulation |
E130557
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: EU medicines regulation | Statement: [Regulation (EC) No 1902/2006, field, EU medicines regulation]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: EU medicines regulation Context triple: [Regulation (EC) No 1902/2006, field, EU medicines regulation]
-
A.
European Union pharmaceutical legislation
chosen
European Union pharmaceutical legislation is the body of EU laws and regulations that governs the authorization, supervision, safety, and quality of medicines for human and veterinary use across member states.
-
B.
European medicines regulatory authorities
European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
-
C.
European Union medical device regulations
European Union medical device regulations are a comprehensive set of legal and technical requirements governing the safety, performance, quality management, and market approval of medical devices within EU member states.
-
D.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
E.
European Union Drugs Agency
The European Union Drugs Agency is the EU’s central body responsible for providing scientific analysis, monitoring, and policy support on drugs and drug addiction across member states.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e11e4da7048190b4387d422a9a0de5 |
completed | April 16, 2026, 5:37 p.m. |
| NER | Named-entity recognition | batch_69f158b739b88190a7f1f20fd1e9b188 |
completed | April 29, 2026, 1:02 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_6a0ae9cfabe081908d6a001bcfe5372c |
completed | May 18, 2026, 10:28 a.m. |
Created at: April 16, 2026, 8:46 p.m.